New Approach to Large-Scale Single-Cell Profiling Developed
A new experimental pipeline has been developed to profile more cell types from different tissues, incorporating machine learning to collate the data and assemble the cell atlas.
Stay updated with breaking news from Broad Cancer Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new experimental pipeline has been developed to profile more cell types from different tissues, incorporating machine learning to collate the data and assemble the cell atlas.
MD Anderson and Broad Institute Launch Translational Research Platform Focused on Rare Cancers Share Rare Daily Staff The University of Texas MD Anderson Cancer Center and the Broad Institute of MIT and Harvard launched a translational research platform to study rare cancers and develop a first-of-its-kind resource for the scientific community. The joint initiative will create a catalog of rare cancer models and provide a data resource to accelerate the identification of therapeutics to treat patients diagnosed with rare tumor types. The National Cancer Institute defines a rar...
Date Time MD Anderson and Broad Institute launch new translational research platform focused on rare cancers The University of Texas MD Anderson Cancer Center and the Broad Institute of MIT and Harvard today announced the launch of a new translational research platform to study rare cancers and develop a first-of-its-kind resource for the scientific community. The joint initiative will create a catalog of rare cancer models and provide a data resource to accelerate the identification of therapeutics to treat patients diagnosed with rare tumor types. The National Cancer Institute defines a rar...
New translational research platform launched to study rare cancers The University of Texas MD Anderson Cancer Center and the Broad Institute of MIT and Harvard today announced the launch of a new translational research platform to study rare cancers and develop a first-of-its-kind resource for the scientific community. The joint initiative will create a catalog of rare cancer models and provide a data resource to accelerate the identification of therapeutics to treat patients diagnosed with rare tumor types. The National Cancer Institute defines a rare cancer as one with fewer than 40,000 new...